Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (10)

2024

  1. G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1

    Cell Death and Disease, Vol. 15, Núm. 11

2013

  1. In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes

    European Journal of Immunology, Vol. 43, Núm. 7, pp. 1933-1939

2011

  1. Evaluation of multiple serum markers in advanced melanoma.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, Vol. 32, Núm. 6, pp. 1155-1161

2010

  1. Evaluation of HLA-G5 Plasmatic Levels During Pregnancy and Relationship with the 14-bp Polymorphism

    American Journal of Reproductive Immunology, Vol. 64, Núm. 5, pp. 367-374

2009

  1. Detection of 3-nitrotyrosine-modified human leukocyte antigen-G in biological fluids

    Human Immunology, Vol. 70, Núm. 12, pp. 976-980

  2. Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu

    Immunology, Vol. 126, Núm. 3, pp. 436-445

  3. Tyrosine nitration in the human leucocyte antigen-G-binding domain of the Ig-like transcript 2 protein

    FEBS Journal, Vol. 276, Núm. 15, pp. 4233-4243

2008

  1. Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages

    Immunology Letters, Vol. 117, Núm. 1, pp. 91-95

  2. Preliminary results of the combination of bevacizumab and weekly paclitaxel in advanced melanoma

    Oncology, Vol. 74, Núm. 1-2, pp. 12-16

2007

  1. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: Longitudinal study during pregnancy

    Human Immunology, Vol. 68, Núm. 8, pp. 661-667